About Oxford Endovascular
Oxford Endovascular is a company based in Oxford (United Kingdom) founded in 2015.. Oxford Endovascular has raised $22.72 million across 8 funding rounds from investors including University of Oxford, EIT Health and European Union. The company has 7 employees as of October 31, 2021. Oxford Endovascular offers products and services including OxiFlow. Oxford Endovascular operates in a competitive market with competitors including Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Fluid Biomed, among others.
- Headquarter Oxford, United Kingdom
- Employees 7 as on 31 Oct, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oxford Endovascular Limited
- Date of Incorporation 09 Sep, 2015
- Jurisdiction OXFORD, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$22.72 M (USD)
in 8 rounds
-
Latest Funding Round
$10.16 M (USD), Series A
May 20, 2024
-
Investors
University of Oxford
& 9 more
-
Employee Count
7
as on Oct 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oxford Endovascular
Oxford Endovascular offers a comprehensive portfolio of products and services, including OxiFlow. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Diverts blood flow to prevent aneurysm rupture safely.
Funding Insights of Oxford Endovascular
Oxford Endovascular has successfully raised a total of $22.72M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $10.16 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $10.2M
- First Round First Round
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series A - Oxford Endovascular | Valuation |
investors |
|
| Nov, 2021 | Amount | Grant - Oxford Endovascular | Valuation |
investors |
|
| Apr, 2021 | Amount | Series A - Oxford Endovascular | Valuation | Vulpes Investment Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oxford Endovascular
Oxford Endovascular has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Oxford, EIT Health and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Early-stage tech and offline investments are managed across sectors.
|
Founded Year | Domain | Location | |
|
Investment management services for science ventures are provided in Oxford.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oxford Endovascular
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oxford Endovascular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oxford Endovascular Comparisons
Competitors of Oxford Endovascular
Oxford Endovascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, CoAxia, Cerus Endovascular, Anaconda Biomed and Fluid Biomed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| domain | founded_year | HQ Location |
Catheter-based treatment for cerebral ischemia
|
|
| domain | founded_year | HQ Location |
Interventional neuroradiology devices are developed for minimally invasive aneurysm treatment.
|
|
| domain | founded_year | HQ Location |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| domain | founded_year | HQ Location |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oxford Endovascular
Frequently Asked Questions about Oxford Endovascular
When was Oxford Endovascular founded?
Oxford Endovascular was founded in 2015.
Where is Oxford Endovascular located?
Oxford Endovascular is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Oxford Endovascular a funded company?
Oxford Endovascular is a funded company, having raised a total of $22.72M across 8 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Dec 21, 2015.
How many employees does Oxford Endovascular have?
As of Oct 31, 2021, the latest employee count at Oxford Endovascular is 7.
What does Oxford Endovascular do?
Oxford Endovascular was established in 2015 as a spin-out from the University of Oxford in the United Kingdom. Focus is placed on the medical device sector, specifically neurovascular treatments. Operations involve the creation of laser-cut metal alloy tubes that are delivered via catheter into brain blood vessels. These devices expand to form meshes that redirect blood flow, supporting aneurysm healing. Development occurs in Oxford, targeting patients with neurovascular conditions.
Who are the top competitors of Oxford Endovascular?
Oxford Endovascular's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
What products or services does Oxford Endovascular offer?
Oxford Endovascular offers OxiFlow.
Who are Oxford Endovascular's investors?
Oxford Endovascular has 10 investors. Key investors include University of Oxford, EIT Health, European Union, EIC Fund, and Vulpes.